Evidence map›Paper›PMID 41414922›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Chemistry in Transformation: A European Moment.

Javier García-Martínez

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Chemistry in Transformation: A European Moment.Angewandte Chemie (International ed. in English) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Javier García-MartínezDepartamento de Química Inorgánica, Laboratorio de Nanotecnología Molecular, Universidad de Alicante, Carretera San Vicente s/n, Alicante, 03690, Spain.ORCID https://orcid.org/0000-0002-7089-4973

Funding

Generalitat Valenciana CIPROM/2023/2HORIZON EUROPE Framework Programme 872102Ministerio de Ciencia, Innovación y Universidades PID2021-1287610B-C21
6 · The paper itself

Abstract

Chemistry stands at a pivotal juncture, facing unprecedented expectations to decarbonize, enable circularity, and sustain essential sectors, while remaining globally competitive. Europe embodies these pressures acutely. Although the region excels in frontier research, structural disadvantages such as high energy and feedstock costs, fragmented regulation, slow permitting, and constrained capital limit its capacity to translate scientific leadership into industrial success. The energy crisis of 2022 exposed long-standing vulnerabilities, triggering capacity closures in foundational value chains such as ammonia and olefins and accelerating the erosion of Europe`s market share. Yet chemistry`s transformation is driven not only by economic asymmetry, but by deeper shifts: the urgency of decarbonization, the need for molecular circularity, and the integration of digital technologies into discovery and manufacturing. Breakthroughs in electrification, advanced catalysts, CO

Indexed as

Chemical industryDecarbonizationDigitalizationIndustrial competitivenessResponsible innovation

Identifiers

PMID41414922
PMCPMC12828443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.